Table 1 Parameters of the screening model.

From: Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness

Model component

Parameter

Baseline estimate

Mininum estimate

Maximum estimate

Reference

Tumour induction due to radiation risk

Dose (mSv)

3

1

5

Peer et al (1993)

 

The lifetime probability of tumour induction

0.51

0.28

0.83

Preston et al (2002)

Preclinical tumour growth

Mean preclinical period (years)

    
 

 <50 years

1.9

0.63

3.17

Peer et al (1996); Tilanus-Linthorst et al (2007); Kriege et al (2006)

 

 50–70 years

3.7

1.23

6.17

 
 

 >70 years

4.5

1.50

7.50

 
 

s.d. (years)

    
 

 <50 years

0.63

0.21

1.05

(Peer et al, 1996; Tilanus-Linthorst et al, 2007; Kriege et al, 2006)

 

 50–70 years

0.51

0.17

0.85

 
 

 >70 years

1.06

0.35

1.77

 
 

Tumour-doubling times (days)

    
 

 <50 years

80

27

133

Peer et al (1996); Tilanus-Linthorst et al (2007); Kriege et al (2006))

 

 50–70 years

157

52

262

 
 

 >70 years

188

63

313

 

Risk of developing breast during life

BRCA1 probability function

    
 

 Lifetime risk at age 70 years

0.80

0.71

0.84

Easton et al (1995); Ford et al (1998)

 

 Mean age (years)

53.9

43.9

63.9

 
 

 s.d. (years)

16.5

5.5

28

 
 

BRCA2 probability function

    
 

 Lifetime risk at age 70 years

0.76

0.69

0.76a

Easton et al (1995); Ford et al (1998)

 

 Mean age (years)

58.5

48.5

68.5

 
 

 s.d. (years)

13.8

4.6

23

 

Sensitivity

Sensitivity of mammography at age <40 years

0.333

0.279

0.397

Kerlikowske et al (2000)

 

Sensitivity of mammography at age 40–49 years

0.389

0.326

0.464

 
 

Sensitivity of mammography at age 50–54

0.556

0.466

0.663

 
 

Sensitivity of mammography at age 55–59 years

0.697

0.584

0.832

 
 

Sensitivity of mammography at age 60 years

0.838

0.702

1

 
 

Sensitivity of MRI for all age groups

0.770

0.593

1

Warner et al (2008)

Specificity

Specificity of mammography at age <40 years

0.961

0.924

1

Kerlikowske et al (2000)

 

Specificity of mammography at age 40 years

0.946

0.909

0.984

 
 

Specificity of MRI for all age groups

0.863

0.745

1

Warner et al (2008)

Death rate

Average life expectancy population (years)

79

www.RIVM.nl

 

5-year survival rate breast cancer patients

   

www.cijfersoverkanker.nl

 

 Tumour diameter <20 mm

0.98

 
 

 Tumour diameter 20–50 mm

0.86

 
 

 Tumour diameter >50 mm

0.62

 
  1. Minimum and maximum estimates correspond with two times the s.d. For a detailed description of the parameters, see Heijnsdijk et al (2012).
  2. aThe maximum estimate is equal to the baseline estimate because the lifetime risk at the age of 100 years is 100%.